ROUNDTABLE SESSION 1 - REGISTER FOR YOUR ROUNDTABLE
Tuesday, April 16, 2024 11:30 AM to 12:00 PM ยท 30 min. (US/Pacific)
Roundtables
Interactive Roundtable
Room 6b
Information
The roundtable session will comprise of two 30 minute discussions, the first running from 11:30-12:00, the second from 12:05-12:35. Please sign up for the two roundtable discussions (one in each session) you are interested in
Roundtables
Bispecific antibody engineering: challenges, strategies
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Antibody Roundtables
Drugging the unreachable: strategies for tissue-specific intracellular delivery
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Antibody Roundtables
Antibody-Drug Conjugate QC strategies
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Antibody Roundtables
Beyond mAbs: considerations for developing antibody-like biologics
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Antibody Roundtables
From CQAs to a control strategy
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Antibody Roundtables
Implementing AI into antibody discovery and engineering
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Antibody Roundtables
Why have virtually all drug targets in fibrotic diseases failed to produce effective therapies, and how can we improve on this?
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Antibody Roundtables
Purification Strategies for bispecific antibodies
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Antibody Roundtables
Intracellular delivery methods
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Antibody Roundtables
Raising Capital as the Biotech Winter Thaws
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Immunotherapy Roundtables
Sex Bias in Autoimmunity and Other Barriers To Precision Medicine
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Immunotherapy Roundtables
Overcoming the tumour microenvironment for effective immunotherapy
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Immunotherapy Roundtables
Opportunities and challenges with multiplex immunofluorescence technologies for immunotherapy
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Immunotherapy Roundtables
Challenges in Immunotherapy Clinical Trial Design
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Immunotherapy Roundtables
A new era of autoimmune disease treatment using mRNA
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Immunotherapy Roundtables
Biomarkers in Translational Medicine
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Immunotherapy Roundtables
Advances in allogenic cell therapy
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Immunotherapy Roundtables
Pros and Cons of Immune Checkpoint Inhibition; whats next?
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Immunotherapy Roundtables
Sustainability of the industry
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Biosimilars Roundtables
Future pipeline development of biosimilars
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Biosimilars Roundtables
The impact of Interchangeability on biosimilar development
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Biosimilars Roundtables
Risk-Based Quality Management in Clinical Trials
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Clinical Trials Roundtables
Clinical Trials Site Relationships
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Clinical Trials Roundtables
Drug Substance Development Strategies
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Manufacturing Roundtables
Advances in Process Analytical Technologies (PAT) for upstream bioprocessing
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Manufacturing Roundtables
Streamlining biosimilar development, from a regulatory perspective
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Biosimilars Roundtables
AAV as a Vector for Gene Therapy Delivery
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Immunotherapy Roundtables
Formulation development strategies
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Manufacturing Roundtables
Applications of AI in Clinical Trials
Tuesday, April 16, 2024 11:30 AM to 12:00 PM
Clinical Trials Roundtables